Company profile
Plant-Based Investment Corp.
OTC: CWWBF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Toronto, ONReports USD
#1417 of 1,417 Healthcare companies by revenue73rd-percentile growth
EA Score
——FH —DQ —GM —SS 21
v0.1 · 5/100 weight · pillars only
↑ balance-sheet leverage, return on assets · ↓ 3-yr revenue growth, market scale
Methodology →Revenue TTM
-$4.4M
Rev growth YoY (TTM)
-218.9%
Net income (FY)
-$6.3M
Employees
—
as of 2026-07-12
Market cap
$275
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue-$3.5M-$3.5M2021
Net income-$6.3M-$6.3M2021
Operating income-$7.8M-$7.8M2021
Total assets$19.9M$19.9M2021
Liabilities$1.7M$1.7M2021
Equity$18.2M$18.2M2021
Revenue trend
FY2018 – FY2021 · USD
FY18
FY19
FY20
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Plant-Based Investment Corp.’s revenue?
Plant-Based Investment Corp. booked -$3.5M in FY2021 revenue, growing 34% year over year — faster than most Healthcare companies we track, at a 177.7% net margin.
Key facts
CEOPaul Jason Crath
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersToronto, ON
ExchangeOTC: CWWBF
Employees—
IPO date2018-03-02
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.